|
|
||||||||
RECEPTORS AND SIGNAL TRANSDUCTION
-controlled ERK1/2 activity within the nucleus
Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, Florida
Submitted 12 December 2005 ; accepted in final form 18 May 2006
High-affinity binding of angiotensin II (ANG II) to the ANG II type 1 receptor (AT1R) results in the activation of ERK1/2 mitogen-activated protein kinases (MAPK). However, the precise mechanism of ANG II-induced ERK1/2 activation has not been fully characterized. Here, we investigated the signaling events leading to ANG II-induced ERK1/2 activation using a c-Src/Yes/Fyn tyrosine kinase-deficient mouse embryonic fibroblast (MEF) cell line stably transfected with the AT1R (SYF/AT1). ERK1/2 activation was reduced by
50% within these cells compared with wild-type controls (WT/AT1). The remaining
50% of intracellular ERK1/2 activation was dependent upon heterotrimeric G protein and protein kinase C zeta (PKC
) activation. Therefore, ANG II-induced ERK1/2 activation occurs via two independent mechanisms. We next investigated whether a loss of either c-Src/Yes/Fyn or PKC
signaling affected ERK1/2 nuclear translocation and cell proliferation in response to ANG II. ANG II-induced cell proliferation was markedly reduced in SYF/AT1 cells compared with WT/AT1 cells (P < 0.01), but interestingly, ERK2 nuclear translocation was normal. ANG II-induced nuclear translocation of ERK2 was blocked via pretreatment of WT/AT1 cells with a PKC
pseudosubstrate. ANG II-induced cell proliferation was significantly reduced in PKC
pseudosubstrate-treated WT/AT1 cells (P < 0.01) and was completely blocked in SYF/AT1 cells treated with this same compound. Thus ANG II-induced cell proliferation appears to be regulated by both ERK1/2-driven nuclear and cytoplasmic events. In response to ANG II, the ability of ERK1/2 to remain within the cytoplasm or translocate into the nucleus is controlled by c-Src/Yes/Fyn or heterotrimeric G protein/PKC
signaling, respectively.
Src family tyrosine kinases; angiotensin II
This article has been cited by other articles:
![]() |
K. Graf Pulmonary hyperplasia and the two sides of PKC{zeta} Cardiovasc Res, June 1, 2008; 78(3): 409 - 410. [Full Text] [PDF] |
||||
![]() |
X. C. Li and J. L. Zhuo Intracellular ANG II directly induces in vitro transcription of TGF-{beta}1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1034 - C1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Olson, P. E. Shamhart, J. E. Naugle, and J. G. Meszaros Angiotensin II-Induced Extracellular Signal-Regulated Kinase 1/2 Activation Is Mediated by Protein Kinase C{delta} and Intracellular Calcium in Adult Rat Cardiac Fibroblasts Hypertension, March 1, 2008; 51(3): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moreno, G. Frazziano, A. Cogolludo, L. Cobeno, J. Tamargo, and F. Perez-Vizcaino Role of Protein Kinase C{zeta} and Its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary Arteries Mol. Pharmacol., November 1, 2007; 72(5): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fernandez-Lopez, E. M. Garrido-Martin, F. Sanz-Rodriguez, M. Pericacho, A. Rodriguez-Barbero, N. Eleno, J. M. Lopez-Novoa, A. Duwell, M. A. Vega, C. Bernabeu, et al. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia Hum. Mol. Genet., July 1, 2007; 16(13): 1515 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Godeny and P. P. Sayeski ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1 Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1308 - C1317. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |